Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients

Author(s):
Baas, J.M.; Krens, L.L.; Tije, A.J. ten; Erdkamp, F.; Wezel, T. van; Morreau, H.; Gelderblom, H.; Guchelaar, H.J. (0000-0002-7085-1383)
Published
2015
Publication type
Article / Letter to editor
KRASColorectal cancerCetuximabStatin
Date issued
2015-12-31
Language
English
Is part of
hdl
1887/107175
doi
10.1007/s10637-015-0285-8